Myriad Genetics buy Piper Sandler
Start price
11.11.25
/
50%
€5.70
Target price
11.11.26
€7.36
Performance (%)
13.16%
Price
27.11.25
€6.45
Summary
This prediction is currently active. The prediction currently has a performance of 13.16%. This prediction currently runs until 11.11.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Myriad Genetics | 19.469% |
| iShares Core DAX® | 2.119% |
| iShares Nasdaq 100 | 1.877% |
| iShares Nikkei 225® | 1.760% |
| iShares S&P 500 | 1.962% |
Comments by Piper_Sandler for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics (NASDAQ:MYGN) had its price target lowered by analysts at Piper Sandler from $9.00 to $8.50. They now have an "overweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat